Moderna Vaccine Approval

FDA to tighten vaccine approval

Moderna (MRNA): Reassessing Valuation After FDA Signals Tougher Vaccine Approval Standards

Moderna (MRNA) slipped about 6% after an FDA official said future vaccine approvals will face tougher scrutiny, a shift tied to a review of reported child fatalities following COVID 19 vaccinations. See our latest analysis for Moderna.

· 2d · on MSN

Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals

· 2d · on MSN

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Investor's Business Daily on MSN

Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10

Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed ...

USA Today

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, ...

JD Supra

European Commission Approves Moderna’s Updated COVID-19 Vaccine

On July 30, 2025, Moderna announced that the European Commission (EC) granted marketing authorization for the updated formulation of Moderna’s COVID-19 vaccine Spikevax®. The updated vaccine ...

3don MSN

FDA links 10 children's deaths to COVID-19 vaccines. Doctors want proof

The top vaccine chief at the Food and Drug Administration sent out a memo saying the FDA will seek a stricter review and ...

Reuters

EXCLUSIVE As Olympics loom, Japanese approval of Moderna's COVID-19 vaccine unlikely till May

TOKYO (Reuters) - Moderna Inc's COVID-19 vaccine is unlikely to win approval in Japan until May due to requirements for local clinical trials, the distributor said, casting doubt over a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results